Know Cancer

or
forgot password

Circulating Tumor Cells (CTCs): A Potential Screening Test for Clinically Undetectable Breast Carcinoma


N/A
18 Years
N/A
Open (Enrolling)
Both
Breast Abnormality

Thank you

Trial Information

Circulating Tumor Cells (CTCs): A Potential Screening Test for Clinically Undetectable Breast Carcinoma


Inclusion Criteria:



- Adults 18 years of age or older

- Mentally competent and willing to provide written informed consent prior to entering
the study

- Military healthcare beneficiary

- Undergoing a diagnostic or therapeutic procedure (biopsy, lumpectomy, mastectomy) in
the breast clinic or operating room.

- Present to the CBCP and willing to be followed at the CBCP during the course of
treatment and follow-up

Exclusion Criteria:

- Prior history of invasive carcinoma

- Presence of clinically-apparent metastatic disease

- Participants with known human immunodeficiency virus (HIV), any history of hepatitis,
prion-mediated disease, drug resistant tuberculosis or other infectious disease
presenting a significant risk to personnel handling tissue or blood-derived products
shall be excluded from participation

- Participants with pre-existing coagulopathies or all other conditions, for whom
invasive biopsy or surgery is medically contraindicated

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Authority:

United States: Federal Government

Study ID:

354344

NCT ID:

NCT01322750

Start Date:

December 2010

Completion Date:

January 2023

Related Keywords:

  • Breast Abnormality
  • Congenital Abnormalities
  • Breast Neoplasms
  • Carcinoma
  • Neoplastic Cells, Circulating

Name

Location

Walter Reed Army Medical CenterWashington, District of Columbia  20307-5000